Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Olive

Showing results (131-140 of 276) with videos related to

Pageof 28
Sort By:
Biomedicines|July 2, 2021
Endometrial Carcinoma: Immune Microenvironment and Emerging Treatments in Immuno-OncologySandrine Rousset-Rouviere, Philippe Rochigneux, Anne-Sophie Chrétien, et al.
Frontiers in Immunology|January 5, 2023
Macrophages and γδ T cells interplay during SARS-CoV-2 variants infectionPerla Abou Atmeh, Laetitia Gay, Anthony Levasseur, et al.
Oncogene|December 3, 2003
Functional interaction of RasGAP-binding proteins Dok-1 and Dok-2 with the Tec protein tyrosine kinaseAudrey Gérard, Cédric Favre, Fabien Garçon, et al.
The Journal of Clinical Investigation|December 30, 2009
BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccinationLaurent Derré, Jean-Paul Rivals, Camilla Jandus, et al.
European Journal of Immunology|June 4, 2014
Vγ9Vδ2 TCR-activation by phosphorylated antigens requires butyrophilin 3 A1 (BTN3A1) and additional genes on human chromosome 6Felipe Riaño, Mohindar M Karunakaran, Lisa Starick, et al.
AIDS (London, England)|April 5, 2014
Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failureSofiane Mohamed, Guillaume Penaranda, Dimitri Gonzalez, et al.
Frontiers in Immunology|May 7, 2021
Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell CarcinomaEmilien Billon, Brice Chanez, Philippe Rochigneux, et al.
Blood|September 6, 2005
Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantationMohamad Mohty, Didier Blaise, Catherine Faucher, et al.
Oncoimmunology|March 26, 2019
Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinomaBenjamin Bian, Daniele Fanale, Nelson Dusetti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 3, 2012
Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blastsJulie Gertner-Dardenne, Remy Castellano, Emilie Mamessier, et al.
Pageof 28

Showing results (131-140 of 276) with videos related to

Sort By:
Pageof 28
Biomedicines|July 2, 2021
Endometrial Carcinoma: Immune Microenvironment and Emerging Treatments in Immuno-OncologySandrine Rousset-Rouviere, Philippe Rochigneux, Anne-Sophie Chrétien, et al.
Frontiers in Immunology|January 5, 2023
Macrophages and γδ T cells interplay during SARS-CoV-2 variants infectionPerla Abou Atmeh, Laetitia Gay, Anthony Levasseur, et al.
Oncogene|December 3, 2003
Functional interaction of RasGAP-binding proteins Dok-1 and Dok-2 with the Tec protein tyrosine kinaseAudrey Gérard, Cédric Favre, Fabien Garçon, et al.
The Journal of Clinical Investigation|December 30, 2009
BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccinationLaurent Derré, Jean-Paul Rivals, Camilla Jandus, et al.
European Journal of Immunology|June 4, 2014
Vγ9Vδ2 TCR-activation by phosphorylated antigens requires butyrophilin 3 A1 (BTN3A1) and additional genes on human chromosome 6Felipe Riaño, Mohindar M Karunakaran, Lisa Starick, et al.
AIDS (London, England)|April 5, 2014
Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failureSofiane Mohamed, Guillaume Penaranda, Dimitri Gonzalez, et al.
Frontiers in Immunology|May 7, 2021
Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell CarcinomaEmilien Billon, Brice Chanez, Philippe Rochigneux, et al.
Blood|September 6, 2005
Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantationMohamad Mohty, Didier Blaise, Catherine Faucher, et al.
Oncoimmunology|March 26, 2019
Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinomaBenjamin Bian, Daniele Fanale, Nelson Dusetti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 3, 2012
Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blastsJulie Gertner-Dardenne, Remy Castellano, Emilie Mamessier, et al.
Pageof 28